Herbs (Global Traditional) · Traditional Chinese Medicine
Sweet Annie (Artemisia annua) (Artemisia annua)
Strong Evidencebotanical
Hermetica Superfood Encyclopedia
Sweet Annie (Artemisia annua) contains artemisinin and its derivatives, which exhibit antimalarial activity by generating reactive oxygen species that damage parasitic cell membranes. The herb also demonstrates anti-inflammatory effects through cyclooxygenase inhibition and antioxidant properties via phenolic compounds.
Sweet Annie (Artemisia annua) is an annual herbaceous plant native to temperate regions of Asia, particularly China, now cultivated globally for medicinal use. The aerial parts (leaves and flowering tops) are harvested and prepared as dried herb for aqueous or ethanolic extracts, teas, or essential oils.
Human clinical trials on whole-plant Artemisia annua are limited, with most evidence from animal/in vitro studies. One clinical trial compared whole-herb A. annua to chloroquine for malaria, showing organic extracts were more effective and faster-acting (specific PMID not provided in sources). No large-scale meta-analyses or RCTs exist for other conditions like hay fever or autoimmune disorders.
Animal studies used 100-390 mg/kg aqueous extracts for 2-4 weeks (antidiabetic/antihypertensive) or 200 mg/kg methanolic extracts (anti-inflammatory). No standardized human dosages established for whole herb preparations. Artemisinin content varies 0.01-1.6% in leaves depending on cultivar. Consult a healthcare provider before starting any new supplement.
Sweet Annie (Artemisia annua) is not consumed as a food for macronutrient value but is valued for its complex phytochemical profile. **Key Bioactive Compounds:** • Artemisinin (sesquiterpene lactone): 0.01–1.4% dry weight depending on cultivar, harvest time, and geographic origin; the primary antimalarial compound; poor water solubility limits oral bioavailability (~32% in animal models), improved when consumed as whole-plant tea or with lipid-based preparations. • Dihydroartemisinic acid: precursor to artemisinin, present at 0.5–1.0% dry weight in high-yielding chemotypes. • Artemisinic acid: ~0.2–0.8% dry weight. **Flavonoids (total flavonoid content ~1.5–3.0% dry weight):** • Casticin: ~0.01–0.05% dry weight; demonstrated synergistic effects with artemisinin against Plasmodium species. • Artemetin: ~0.01–0.04% dry weight. • Chrysosplenol-D: trace to ~0.03% dry weight. • Eupatorin and cirsilineol: present in smaller quantities. These polymethoxylated flavonoids may enhance artemisinin bioavailability by inhibiting cytochrome P450 metabolism and MDR1 efflux. **Phenolic Acids:** • Chlorogenic acid, caffeic acid, and rosmarinic acid contribute to total phenolic content of approximately 20–45 mg gallic acid equivalents (GAE)/g dry extract. **Essential Oil (~0.3–1.4% of dry weight):** • Camphor: ~15–45% of essential oil. • 1,8-Cineole (eucalyptol): ~5–15%. • Artemisia ketone: ~5–25%. • Germacrene-D, β-caryophyllene, α-pinene: minor constituents. **Terpenoids:** • Scopoletin (coumarin): trace amounts. • β-Sitosterol and stigmasterol: present in lipophilic fractions. **Minerals (approximate, per dry herb):** • Potassium: ~15–25 mg/g. • Calcium: ~5–12 mg/g. • Magnesium: ~2–5 mg/g. • Iron: ~0.2–0.8 mg/g. • Zinc: ~0.03–0.08 mg/g. • Selenium: trace amounts detected in some cultivars. **Vitamins:** • Vitamin C: modest amounts (~0.1–0.5 mg/g dry weight). • Vitamin E (tocopherols): trace amounts in lipid fraction. • Provitamin A (β-carotene): minimal. **Fiber & Protein:** • Crude protein: ~10–16% dry weight (not a practical dietary source). • Crude fiber: ~15–22% dry weight. **Bioavailability Notes:** Artemisinin has low aqueous solubility and undergoes extensive first-pass hepatic metabolism via CYP2B6 and CYP3A4, with autoinduction reducing bioavailability upon repeated dosing. Whole-plant preparations (dried leaf infusions or powdered leaf capsules) may deliver 40–80× more artemisinin to the bloodstream compared to equivalent doses of purified artemisinin, likely due to co-extracted flavonoids and lipophilic compounds that inhibit CYP enzymes and intestinal efflux pumps. Fat-soluble components are better absorbed with dietary lipids. Tea infusions extract only ~30–50% of available artemisinin due to its hydrophobic nature.
Artemisinin and its derivatives generate reactive oxygen species when exposed to iron, creating free radicals that damage Plasmodium parasite cell membranes and proteins. The anti-inflammatory effects occur through inhibition of cyclooxygenase (COX) enzymes and nuclear factor-kappa B (NF-κB) signaling pathways. Phenolic compounds like caffeic acid and chlorogenic acid provide antioxidant activity by scavenging free radicals and chelating metal ions.
Clinical trials show organic extracts of Sweet Annie demonstrated superior antimalarial activity compared to chloroquine, though evidence quality remains limited with small sample sizes. Animal studies using 200 mg/kg dosages showed 55-60% inhibition of induced edema, comparable to diclofenac effectiveness. Antioxidant studies are primarily in vitro, showing high DPPH radical scavenging activity but lacking human clinical validation. Most research focuses on isolated artemisinin rather than whole plant extracts, limiting conclusions about traditional preparations.
Sweet Annie may cause gastrointestinal upset, dizziness, and tinnitus at high doses, particularly with concentrated artemisinin preparations. The herb can interact with anticoagulant medications due to potential effects on cytochrome P450 enzymes, particularly CYP2B6 and CYP3A4. Pregnancy and breastfeeding safety has not been established, and traditional use suggests avoiding during early pregnancy. Individuals with known allergies to Asteraceae family plants should exercise caution.
